Richard Abbott
Fortune : 23 946 $ au 30/09/2026
Fortune : 23 946 $ au 30/09/2026
Richard Abbott is currently President at Co-Diagnostics, Inc. since 2024.
Formerly, Mr. Abbott was President at Advanced Conceptions, Inc. from 2021 to 2024, Chief Technology Officer at Fenome, Inc. from 2016 to 2017, and Vice President-Engineering at Biofire Diagnostics LLC from 1998 to 2014.
Education includes undergraduate and graduate degrees from Brigham Young University and an MBA from The Wharton School of the University of Pennsylvania.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/07/2026 | 22 379 ( 0,3% ) | 23 946 $ | 30/09/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CO-DIAGNOSTICS, INC. | President | 15/03/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Advanced Conceptions, Inc.
Advanced Conceptions, Inc. Medical SpecialtiesHealth Technology Develops diagnostic and therapeutic devices | President | 01/03/2024 |
Fenome, Inc. | Directeur Technique/Scientifique/R&D | 01/07/2017 |
Biofire Diagnostics, Inc.
Biofire Diagnostics, Inc. Electronic Production EquipmentElectronic Technology Manufactures, markets and sales of the film array system | Corporate Officer/Principal | 01/12/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biofire Diagnostics, Inc.
Biofire Diagnostics, Inc. Electronic Production EquipmentElectronic Technology Manufactures, markets and sales of the film array system | Electronic Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Co-Diagnostics, Inc.
Co-Diagnostics, Inc. BiotechnologyHealth Technology Develops molecular diagnostics products and tests that represents a radical new advancement in the understanding of the molecular interactions of DNA | Health Technology |
Fenome, Inc. | |
Advanced Conceptions, Inc.
Advanced Conceptions, Inc. Medical SpecialtiesHealth Technology Develops diagnostic and therapeutic devices | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national